Research progress of immune checkpoint inhibitors in neoadjuvant immunotherapy for dMMR/MSI-H locally advanced colorectal cancer

In recent years, immune checkpoint inhibitors (ICIs) have made great progress in the treatment of colorectal cancer, particularly in the post-line and first-line treatment of dMMR/MSH-H metastatic colorectal cancer patients, demonstrating good clinical outcomes. Currently, the relevant research and...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhu Xi, Li Yang, Jiang Jun, Li Guoli, Kao Xiaoming
Format: Article
Language:zho
Published: Editorial Office of Journal of Colorectal & Anal Surgery 2024-02-01
Series:结直肠肛门外科
Subjects:
Online Access:https://jcas.gxmuyfy.cn/cn/wqll/paper.html?id=67&cateName=2024%E5%B9%B4%20%E7%AC%AC30%E5%8D%B7%20%E7%AC%AC1%E6%9C%9F
Tags: Add Tag
No Tags, Be the first to tag this record!